 | • レポートコード：MRC23Q36019 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のフルサービス臨床研究機関（CRO）市場について調査・分析し、世界のフルサービス臨床研究機関（CRO）市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（臨床CRO、前臨床CRO）、用途別セグメント分析（中小企業、大企業）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、IQVIA、Labcorp、Syneos Health、PPD、ICON、PRA、Parexel、Medpace、Wuxi Apptec、EPS International、Worldwide Clinical Trials、CMIC、Premier Research、Courante Oncology、PROMETRIKAなどが含まれています。世界のフルサービス臨床研究機関（CRO）市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、フルサービス臨床研究機関（CRO）市場規模を推定する際に考慮しました。本レポートは、フルサービス臨床研究機関（CRO）の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、フルサービス臨床研究機関（CRO）に関するビジネス上の意思決定に役立てることを目的としています。 ・フルサービス臨床研究機関（CRO）市場の概要 - フルサービス臨床研究機関（CRO）のタイプ別セグメント - 世界のフルサービス臨床研究機関（CRO）市場規模：タイプ別分析（臨床CRO、前臨床CRO） - フルサービス臨床研究機関（CRO）の用途別セグメント - 世界のフルサービス臨床研究機関（CRO）市場規模：用途別分析（中小企業、大企業） - 世界のフルサービス臨床研究機関（CRO）市場規模予測（2018年-2029年） ・フルサービス臨床研究機関（CRO）市場の成長トレンド - フルサービス臨床研究機関（CRO）の地域別市場規模（2018年-2029年） - フルサービス臨床研究機関（CRO）市場ダイナミクス - フルサービス臨床研究機関（CRO）の業界動向 - フルサービス臨床研究機関（CRO）市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：臨床CRO、前臨床CRO - 世界のフルサービス臨床研究機関（CRO）のタイプ別市場規模（2018年-2023年） - 世界のフルサービス臨床研究機関（CRO）のタイプ別市場規模（2024年-2029年） ・用途別セグメント：中小企業、大企業 - 世界のフルサービス臨床研究機関（CRO）の用途別市場規模（2018年-2023年） - 世界のフルサービス臨床研究機関（CRO）の用途別市場規模（2024年-2029年） ・フルサービス臨床研究機関（CRO）の地域別市場規模 - 北米のフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - アメリカのフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - ヨーロッパのフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - アジア太平洋のフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - 中国のフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - 日本のフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - 韓国のフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - インドのフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - オーストラリアのフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - 中南米のフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） - 中東・アフリカのフルサービス臨床研究機関（CRO）市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 IQVIA、Labcorp、Syneos Health、PPD、ICON、PRA、Parexel、Medpace、Wuxi Apptec、EPS International、Worldwide Clinical Trials、CMIC、Premier Research、Courante Oncology、PROMETRIKA ・アナリストの観点/結論 ・調査方法とデータソース |
Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.
Highlights
The global Full-Service Clinical Research Organization (CRO) market was valued at US$ 18350 million in 2022 and is anticipated to reach US$ 33230 million by 2029, witnessing a CAGR of 10.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Full-Service Clinical Research Organization (CRO) key players include IQVIA, Labcorp, Syneos Health, PPD, ICON, etc. Global top three players hold a share about 30%. North America is the largest market, with a share about 45%, followed by APAC and Europe, both have a share about 50 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Full-Service Clinical Research Organization (CRO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Full-Service Clinical Research Organization (CRO).
The Full-Service Clinical Research Organization (CRO) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Full-Service Clinical Research Organization (CRO) market comprehensively. Regional market sizes, concerning products by type, by end use, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Full-Service Clinical Research Organization (CRO) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by end use, and by regions.
By Company
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA
Segment by Type
Clinical CRO
Preclinical CRO
Segment by End Use
Small Medium Enterprise
Large Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, end use, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Full-Service Clinical Research Organization (CRO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by end use, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Clinical CRO
1.2.3 Preclinical CRO
1.3 Market by End Use
1.3.1 Global Full-Service Clinical Research Organization (CRO) Market Growth by End Use: 2018 VS 2022 VS 2029
1.3.2 Small Medium Enterprise
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Full-Service Clinical Research Organization (CRO) Market Perspective (2018-2029)
2.2 Full-Service Clinical Research Organization (CRO) Growth Trends by Region
2.2.1 Global Full-Service Clinical Research Organization (CRO) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Full-Service Clinical Research Organization (CRO) Historic Market Size by Region (2018-2023)
2.2.3 Full-Service Clinical Research Organization (CRO) Forecasted Market Size by Region (2024-2029)
2.3 Full-Service Clinical Research Organization (CRO) Market Dynamics
2.3.1 Full-Service Clinical Research Organization (CRO) Industry Trends
2.3.2 Full-Service Clinical Research Organization (CRO) Market Drivers
2.3.3 Full-Service Clinical Research Organization (CRO) Market Challenges
2.3.4 Full-Service Clinical Research Organization (CRO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Full-Service Clinical Research Organization (CRO) Players by Revenue
3.1.1 Global Top Full-Service Clinical Research Organization (CRO) Players by Revenue (2018-2023)
3.1.2 Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Players (2018-2023)
3.2 Global Full-Service Clinical Research Organization (CRO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Full-Service Clinical Research Organization (CRO) Revenue
3.4 Global Full-Service Clinical Research Organization (CRO) Market Concentration Ratio
3.4.1 Global Full-Service Clinical Research Organization (CRO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Full-Service Clinical Research Organization (CRO) Revenue in 2022
3.5 Full-Service Clinical Research Organization (CRO) Key Players Head office and Area Served
3.6 Key Players Full-Service Clinical Research Organization (CRO) Product Solution and Service
3.7 Date of Enter into Full-Service Clinical Research Organization (CRO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Full-Service Clinical Research Organization (CRO) Breakdown Data by Type
4.1 Global Full-Service Clinical Research Organization (CRO) Historic Market Size by Type (2018-2023)
4.2 Global Full-Service Clinical Research Organization (CRO) Forecasted Market Size by Type (2024-2029)
5 Full-Service Clinical Research Organization (CRO) Breakdown Data by End Use
5.1 Global Full-Service Clinical Research Organization (CRO) Historic Market Size by End Use (2018-2023)
5.2 Global Full-Service Clinical Research Organization (CRO) Forecasted Market Size by End Use (2024-2029)
6 North America
6.1 North America Full-Service Clinical Research Organization (CRO) Market Size (2018-2029)
6.2 North America Full-Service Clinical Research Organization (CRO) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Full-Service Clinical Research Organization (CRO) Market Size by Country (2018-2023)
6.4 North America Full-Service Clinical Research Organization (CRO) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Full-Service Clinical Research Organization (CRO) Market Size (2018-2029)
7.2 Europe Full-Service Clinical Research Organization (CRO) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Full-Service Clinical Research Organization (CRO) Market Size by Country (2018-2023)
7.4 Europe Full-Service Clinical Research Organization (CRO) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size (2018-2029)
8.2 Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size by Region (2018-2023)
8.4 Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Full-Service Clinical Research Organization (CRO) Market Size (2018-2029)
9.2 Latin America Full-Service Clinical Research Organization (CRO) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Full-Service Clinical Research Organization (CRO) Market Size by Country (2018-2023)
9.4 Latin America Full-Service Clinical Research Organization (CRO) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size (2018-2029)
10.2 Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size by Country (2018-2023)
10.4 Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Detail
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Full-Service Clinical Research Organization (CRO) Introduction
11.1.4 IQVIA Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.1.5 IQVIA Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Full-Service Clinical Research Organization (CRO) Introduction
11.2.4 Labcorp Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.2.5 Labcorp Recent Development
11.3 Syneos Health
11.3.1 Syneos Health Company Detail
11.3.2 Syneos Health Business Overview
11.3.3 Syneos Health Full-Service Clinical Research Organization (CRO) Introduction
11.3.4 Syneos Health Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.3.5 Syneos Health Recent Development
11.4 PPD
11.4.1 PPD Company Detail
11.4.2 PPD Business Overview
11.4.3 PPD Full-Service Clinical Research Organization (CRO) Introduction
11.4.4 PPD Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.4.5 PPD Recent Development
11.5 ICON
11.5.1 ICON Company Detail
11.5.2 ICON Business Overview
11.5.3 ICON Full-Service Clinical Research Organization (CRO) Introduction
11.5.4 ICON Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.5.5 ICON Recent Development
11.6 PRA
11.6.1 PRA Company Detail
11.6.2 PRA Business Overview
11.6.3 PRA Full-Service Clinical Research Organization (CRO) Introduction
11.6.4 PRA Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.6.5 PRA Recent Development
11.7 Parexel
11.7.1 Parexel Company Detail
11.7.2 Parexel Business Overview
11.7.3 Parexel Full-Service Clinical Research Organization (CRO) Introduction
11.7.4 Parexel Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.7.5 Parexel Recent Development
11.8 Medpace
11.8.1 Medpace Company Detail
11.8.2 Medpace Business Overview
11.8.3 Medpace Full-Service Clinical Research Organization (CRO) Introduction
11.8.4 Medpace Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.8.5 Medpace Recent Development
11.9 Wuxi Apptec
11.9.1 Wuxi Apptec Company Detail
11.9.2 Wuxi Apptec Business Overview
11.9.3 Wuxi Apptec Full-Service Clinical Research Organization (CRO) Introduction
11.9.4 Wuxi Apptec Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.9.5 Wuxi Apptec Recent Development
11.10 EPS International
11.10.1 EPS International Company Detail
11.10.2 EPS International Business Overview
11.10.3 EPS International Full-Service Clinical Research Organization (CRO) Introduction
11.10.4 EPS International Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.10.5 EPS International Recent Development
11.11 Worldwide Clinical Trials
11.11.1 Worldwide Clinical Trials Company Detail
11.11.2 Worldwide Clinical Trials Business Overview
11.11.3 Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Introduction
11.11.4 Worldwide Clinical Trials Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.11.5 Worldwide Clinical Trials Recent Development
11.12 CMIC
11.12.1 CMIC Company Detail
11.12.2 CMIC Business Overview
11.12.3 CMIC Full-Service Clinical Research Organization (CRO) Introduction
11.12.4 CMIC Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.12.5 CMIC Recent Development
11.13 Premier Research
11.13.1 Premier Research Company Detail
11.13.2 Premier Research Business Overview
11.13.3 Premier Research Full-Service Clinical Research Organization (CRO) Introduction
11.13.4 Premier Research Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.13.5 Premier Research Recent Development
11.14 Courante Oncology
11.14.1 Courante Oncology Company Detail
11.14.2 Courante Oncology Business Overview
11.14.3 Courante Oncology Full-Service Clinical Research Organization (CRO) Introduction
11.14.4 Courante Oncology Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.14.5 Courante Oncology Recent Development
11.15 PROMETRIKA
11.15.1 PROMETRIKA Company Detail
11.15.2 PROMETRIKA Business Overview
11.15.3 PROMETRIKA Full-Service Clinical Research Organization (CRO) Introduction
11.15.4 PROMETRIKA Revenue in Full-Service Clinical Research Organization (CRO) Business (2018-2023)
11.15.5 PROMETRIKA Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
